DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain (Q46708448)

24 December 2017

title

DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain (English)

1 reference

24 December 2017

1 reference

J Popp

1

1 reference

24 December 2017

S Leucht

series ordinal

2

1 reference

24 December 2017

S Heres

series ordinal

3

1 reference

24 December 2017

W Steimer

series ordinal

4

1 reference

24 December 2017

publication date

11 March 2008

1 reference

24 December 2017

The Pharmacogenomics Journal

published in

1 reference

24 December 2017

volume

9

1 reference

24 December 2017

issue

1

1 reference

24 December 2017

page(s)

71-77

1 reference

24 December 2017

Nucleus Accumbens Dopamine and the Regulation of Effort in Food-Seeking Behavior: Implications for Studies of Natural Motivation, Psychiatry, and Drug Abuse

cites work

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

Human dopamine D4 receptor gene: frequent occurrence of a null allele and observation of homozygosity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

Multiple dopamine D4 receptor variants in the human population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

Modification of human 5-HT(2C) receptor function by Cys23Ser, an abundant, naturally occurring amino-acid substitution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

Identification, expression, and pharmacology of a Cys23-Ser23 substitution in the human 5-HT2c receptor gene (HTR2C)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

Polymorphisms of the dopamine D4 receptor and response to antipsychotic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

DRD4 exon III polymorphism and response to risperidone in Israeli adolescents with schizophrenia: a pilot pharmacogenetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

Efficacy and side-effects of clozapine not associated with variation in the 5-HT2C receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

Association between a polymorphism of the 5-HT2C receptor and weight loss in teenage girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

Association of the 5-HT2c gene with susceptibility and minimum body mass index in anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

A Cys 23-Ser 23 substitution in the 5-HT(2C) receptor gene influences body weight regulation in females with seasonal affective disorder: an Austrian-Canadian collaborative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

Weight gain associated with the -759C/T polymorphism of the 5HT2C receptor and olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

Clozapine-induced weight gain associated with the 5HT2C receptor -759C/T polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

The 5-HT2C receptor and antipsychoticinduced weight gain - mechanisms and genetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

Weight changes during clozapine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

Cortisol, prolactin, growth hormone and neurovegetative responses to emotions elicited during an hypnoidal state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

Regulation of feeding-associated peptides and receptors by nicotine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

Clozapine and body mass change.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

The dopamine-4 receptor gene associated with binge eating and weight gain in women with seasonal affective disorder: an evolutionary perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

The molecular genetic architecture of human personality: beyond self-report questionnaires

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

Clozapine-induced weight gain: prevalence and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

Association between early and rapid weight gain and change in weight over one year of olanzapine therapy in patients with schizophrenia and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

Pharmacogenetics of antipsychotics: useful for the clinician?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

Efficacy and side-effects of clozapine: testing for association with allelic variation in the dopamine D4 receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2008.5

21 January 2018

Identifiers

DOI

10.1038/TPJ.2008.5

1 reference

24 December 2017

1 reference

24 December 2017